Andreas G Frank
CIK 1529659 · Exec VP/Chief Business Officer · last filed 2024-10-15
Andreas G Frank is an Exec VP/Chief Business Officer who has filed 64 SEC Form 4 insider transactions across 2 companies since 2011. The most recent filing, for XRAY, was dated Oct 15, 2024. Across all open-market trades the lifetime net is −$5.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.1M across reported positions. 50 SEC filings were submitted jointly with HILLENBRAND INDUSTRIES INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
HRC price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
13320 BALLANTYNE CORPORATE PLACE
CHARLOTTE, NC 28277
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XRAY | Exec VP/Chief Business Officer | 119,865 | $9.22 | $1.11M | $0 | 16 | 2024-10-15 |
| Hill-Rom Holdings, Inc. (HRC) Delisted | SVP, Pres. Front Line Care | 16,731 | $155.96 | $2.61M | -$5.64M | 47 | 2021-12-08 |
Recent Filings
64 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-10-15 | XRAY | Grant (A) | +392 | $0 | EDGAR |
| 2024-07-15 | XRAY | Grant (A) | +423 | $0 | EDGAR |
| 2024-05-14 | XRAY | Tax (F) | −14,570 | -$410.6K | EDGAR |
| 2024-04-15 | XRAY | Grant (A) | +503 | $0 | EDGAR |
| 2024-03-19 | XRAY | Grant (A) | — | $0 | EDGAR |
| 2024-03-06 | XRAY | Grant (A) | +16,902 | $0 | EDGAR |
| 2024-03-04 | XRAY | Tax (F) | −1,507 | -$50.1K | EDGAR |
| 2024-01-16 | XRAY | Grant (A) | +362 | $0 | EDGAR |
| 2023-11-17 | XRAY | Tax (F) | −13,674 | -$404.8K | EDGAR |
| 2023-10-16 | XRAY | Grant (A) | +533 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.